The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors
Abstract
Human carbonic anhydrase (hCA) isoenzymes are zinc ion‐containing, widespread metalloenzymes and they classically play a role in pH homeostasis maintenance. CA inhibitors suppress the CA activity and their usage has been clinically established as antiglaucoma agents, antiepileptics, diuretics, and in some other disorders. Alzheimer's disease (AD) is a slowly progressive neurodegenerative disorder and a fatal disease of the brain. An advanced method to cure AD includes the strategy to design acetylcholinesterase (AChE) inhibitors. A novel series of pyrrole‐3‐one derivatives containing sulfa drugs (5a–i) were determined to be highly potent inhibitors for AChE and hCA I and hCA II (inhibitory constant [Ki] values are in the range of 6.50 ± 1.02–37.46 ± 4.12 nM, 1.20 ± 0.19–44.21 ± 1.09 nM, and 8.93 ± 1.58–46.86 ± 8.41 nM for AChE, hCA I, and hCA II, respectively). The designed compounds often show a more effective inhibition than the chemicals used as the standard. Among these compounds, 5f was the most effective compound against hCA I, and compound 5e was the most effective compound against hCA II. It was determined that compound 5c was the most effective inhibitor for AChE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
Daina, A., Michielin, O., & Zoete, V. (2017) · Scientific Reports · doi:10.1038/srep42717 · Cited by 18,367
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
Supuran, C. T., Scozzafava, A., & Casini, A. (2003) · Medicinal Research Reviews · doi:10.1002/med.10025 · Cited by 1,449
Radhakrishnan, A., Nanjappa, V., Raja, R., Sathe, G., Puttamallesh, V. N., Jain, A. P., Pinto, S. M., Balaji, S. A., Chavan, S., Sahasrabuddhe, N. A., et al. (2017) · Scientific Reports · doi:10.1038/srep46864 · Cited by 825
Pyrrole: An insight into recent pharmacological advances with structure activity relationship
Ahmad, S., Alam, O., Naim, M. J., Shaquiquzzaman, M., Alam, M. M., & Iqbal, M. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.002 · Cited by 259
Antioxidant and anticholinergic properties of olivetol
Taslimi, P., & Gulçin, İ. (2018) · Journal of Food Biochemistry · doi:10.1111/jfbc.12516 · Cited by 252
Eruygur, N., Koçyiğit, U. M., Taslimi, P., Ataş, M., Tekin, M., & Gülçin, İ. (2019) · South African Journal of Botany · doi:10.1016/j.sajb.2018.04.001 · Cited by 226
Self-citationAnticholinergic and antioxidant activities of usnic acid-an activity-structure insight
Cetin Cakmak, K., & Gülçin, İ. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.11.003 · Cited by 204
Self-citationPotent Acetylcholinesterase Inhibitors: Potential Drugs for Alzheimer’s Disease
Akıncıoğlu, H., & Gülçın, İ. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200103100521 · Cited by 166
Metadata
- Authors
- Gümüş, M., Babacan, Ş. N., Demir, Y., Sert, Y., Koca, İ., & Gülçin, İ.
- Venue
- Archiv der Pharmazie
- Publisher
- Wiley
- Published
- 2021-10-05
- Volume
- 355
- Issue
- 1
- Pages
- e2100242-e2100242
- ISSN
- 0365-6233 (ISSN-L)
- 1521-4184
- OpenAlex
- W3204952372
- Cited by
- 291
- References
- 20
- FWCI
- 14.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors. https://app.cochat.ai/papers/10.1002/ardp.202100242
- The paper
- Gümüş, M., Babacan, Ş. N., Demir, Y., Sert, Y., Koca, İ., & Gülçin, İ. (2022). Discovery of sulfadrug–pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202100242
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.